CHINA AMNIOTIC MEMBRANE MARKET FORECAST 2023-2030

CHINA AMNIOTIC MEMBRANE MARKET FORECAST 2023-2030
China Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilized Amniotic Membrane) Market by Application (Surgical Wounds, Ophthalmology, Other Applications) Market by End-user (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers & Laboratories)by Geography
The China amniotic membrane market is anticipated to accelerate with an 8.62% CAGR by 2030, and generate $258.97 million during the estimation period, 2023-2030.
Amniotic membranes (AM) or amnions are thin membranes on the inner layer of the fetal placenta. It delimits the amniotic cavity and surrounds the embryo. In recent years, the function and structure of amnions have been particularly investigated for their pluripotent properties, which are an attractive source for tissue transplantation globally.
China is one of the largest amniotic membrane markets in Asia-Pacific. The country is the top producer of medical equipment and disposable accessories. The nation uses an amniotic membrane perforator/amniotomy hook method. Therefore, it is anticipated that the manufacture of disposable accessories will drive most of the market growth. The increasing use of amniotic membranes for treating wounds, traumas, and ocular problems, fuels market expansion.
To know more about this report, request a free sample copy
The China amniotic membrane market assessment includes segmentation by end-user, product, and application. Market by product covers cryopreserved amniotic membrane and lyophilization amniotic membrane.
The freeze-dried and sterilized amniotic membrane, also known as lyophilization, uses the drying by the freezing process to preserve the lyophilized amniotic membrane and is usually used in surgeries of ocular surface reconstruction. Lyophilization enables amniotic membrane tissue to be preserved in a shelf-stable state and conserves the active biological components required for medical use. Lyophilized amniotic membrane is used for a broad range of applications. However, it is widely used to treat a no-healing defect on the ocular surface, such as a neurotrophic corneal ulcer. Also, market players are providing lyophilized amniotic membranes that are easy to use and ideal to handle.
Furthermore, this method reduces the preservation costs and may enhance the use of amniotic membranes, facilitating their storage and transport. Lyophilized amniotic membrane maintains the desirable properties of an ocular bandage and demonstrates improved biocompatibility. Also, they prevent donor morbidity and enable wound management without using classical wound gauze. Thus, owing to the varied advantages lyophilized amniotic membrane offers, it is expected to witness growth in the forecast years.
Some of the key companies operating in the China amniotic membrane market are Integra LifeSciences, MiMedx Group Inc, Organogenesis Inc, etc.
Organogenesis is a leading regenerative medicine company focused on empowering healing through manufacturing, developing, and selling products for advanced wound care, surgical, and sports medicine markets. The company offers products to a wide range of healthcare customers, including wound care centers, hospitals, government facilities, ASCs and physician offices.
In addition, the company’s portfolio entails regenerative medicine products in various stages, like surgical & sports medicine products, commercialized advanced wound care, and preclinical to late-stage development, which support healing across a wide variety of wound types at many different types of facilities. Organogenesis is headquartered in Massachusetts, United States.
NuShield from Organogenesis undergoes an intricate preservation method known as LayerLoc™, which helps retain all the layers of the placental membrane, including the chorion and amnion, with the spongy layer intact. NuShield® may be used in various soft tissue repair applications as a physical barrier to protect the repair site.
On the other hand, Affinity® from Organogenesis is the fresh amniotic membrane barrier for use in appropriate surgical applications. Affinity uses the AlloFresh™ method, a gentle hypothermic storage that preserves the product in its fresh state, retaining its tissue characteristics without dehydrating or freezing. Affinity® may be used in various soft tissue repair applications as a physical barrier to protect the repair site.
Report Synopsis
Report Scope | Details |
Market Forecast Years | 2023-2030 |
Base Year | 2022 |
Market Historical Years | 2018-2021 |
Forecast Units | Revenue ($ Million) |
Segments Analyzed | Product, Application, End-User |
Country Analyzed | China |
Companies Analyzed |
Integra LifeSciences, MiMedx Group Inc, Organogenesis Inc, Smith & Nephew Plc, Stryker Corporation |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- COUNTRY SNAPSHOT
- COUNTRY ANALYSIS
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- IMPACT OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
- MAJOR MARKET FINDINGS
- AMNIOTIC MEMBRANE IS MAJORLY USED FOR OCULAR APPLICATIONS
- STRATEGIC DEVELOPMENTS BY KEY PLAYERS
- MARKET DYNAMICS
- KEY DRIVERS
- INCREASING RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
- GROWING AWARENESS REGARDING NUMEROUS APPLICATIONS OF AMNIOTIC MEMBRANE
- RISING DEMAND FOR WOUND CARE TREATMENT
- KEY RESTRAINTS
- DIFFICULTIES ASSOCIATED WITH AMNIOTIC MEMBRANE USE
- LACK OF SKILLED PROFESSIONALS
- KEY DRIVERS
- KEY ANALYTICS
- KEY MARKET TRENDS
- PESTLE ANALYSIS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- GROWTH PROSPECT MAPPING FOR CHINA
- MARKET MATURITY ANALYSIS
- MARKET CONCENTRATION ANALYSIS
- MARKET BY PRODUCT
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- LYOPHILIZED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET BY APPLICATION
- SURGICAL WOUNDS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OPHTHALMOLOGY
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OTHER APPLICATIONS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SURGICAL WOUNDS
- MARKET BY END-USER
- HOSPITALS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- AMBULATORY SURGICAL CENTERS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SPECIALIZED CLINICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- RESEARCH CENTERS & LABORATORIES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- HOSPITALS
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- COMPANY PROFILES
- INTEGRA LIFESCIENCES
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- MIMEDX GROUP INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- ORGANOGENESIS INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- SMITH & NEPHEW PLC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- STRYKER CORPORATION
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- INTEGRA LIFESCIENCES
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: CHINA MARKET SNAPSHOT – AMNIOTIC MEMBRANE
TABLE 2: CHINA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: CHINA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 4: CHINA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: CHINA AMNIOTIC MEMBRANE MARKET, BY APPLICATION, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 6: CHINA AMNIOTIC MEMBRANE MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: CHINA AMNIOTIC MEMBRANE MARKET, BY END-USER, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 8: CHINA REGULATORY FRAMEWORK
TABLE 9: KEY PLAYERS OPERATING IN CHINA AMNIOTIC MEMBRANE MARKET
TABLE 10: LIST OF ACQUISITIONS
TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR CHINA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: CHINA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022
FIGURE 7: CHINA AMNIOTIC MEMBRANE MARKET, BY CRYOPRESERVED AMNIOTIC MEMBRANE, 2023-2030 (IN $ MILLION)
FIGURE 8: CHINA AMNIOTIC MEMBRANE MARKET, BY LYOPHILIZED AMNIOTIC MEMBRANE, 2023-2030 (IN $ MILLION)
FIGURE 9: CHINA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 10: CHINA AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2023-2030 (IN $ MILLION)
FIGURE 11: CHINA AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2023-2030 (IN $ MILLION)
FIGURE 12: CHINA AMNIOTIC MEMBRANE MARKET, BY OTHER APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 13: CHINA AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 14: CHINA AMNIOTIC MEMBRANE MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 15: CHINA AMNIOTIC MEMBRANE MARKET, BY AMBULATORY SURGICAL CENTRES, 2023-2030 (IN $ MILLION)
FIGURE 16: CHINA AMNIOTIC MEMBRANE MARKET, BY SPECIALIZED CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 17: CHINA AMNIOTIC MEMBRANE MARKET, BY RESEARCH CENTERS & LABORATORIES, 2023-2030 (IN $ MILLION)
FIGURE 18: INTEGRA LIFESCIENCES- COMPANY REVENUE, IN 2017-2021 (IN $ BILLION)
FIGURE 19: INTEGRA LIFESCIENCES- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
FIGURE 20: MIMEDX GROUP INC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)
FIGURE 21: MIMEDX GROUP INC- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
FIGURE 22: ORGANOGENESIS INC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)
FIGURE 23: ORGANOGENESIS INC- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
FIGURE 24: SMITH & NEPHEW PLC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)
FIGURE 25: SMITH & NEPHEW PLC- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
FIGURE 26: STRYKER CORPORATION- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)
FIGURE 27: STRYKER CORPORATION- COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
- MARKET BY PRODUCT
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- LYOPHILIZED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET BY APPLICATION
- SURGICAL WOUNDS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OPHTHALMOLOGY
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OTHER APPLICATIONS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SURGICAL WOUNDS
- MARKET BY END-USER
- HOSPITALS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- AMBULATORY SURGICAL CENTERS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SPECIALIZED CLINICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- RESEARCH CENTERS & LABORATORIES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- HOSPITALS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.